NeuroScientific Biopharmaceuticals
(ASX) NSB
NeuroScientific Biopharmaceuticals Financials at a Glance
Market Cap
$33.26M
Revenue (TTM)
$2.21M
Net Income (TTM)
$1.99M
EPS (TTM)
$-0.02
P/E Ratio
-6.58
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.10
Volume
98,865
Open
$0.10
Price
$0.10
Volume
98,865
Open
$0.10
Previous Close
$0.10
Daily Range
$0.10 - $0.10
52-Week Range
$0.03 - $0.26
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.10
Volume
98,865
Open
$0.10
Previous Close
$0.10
Daily Range
$0.10 - $0.10
52-Week Range
$0.03 - $0.26
NSB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeuroScientific Biopharmaceuticals
Industry
Biotechnology
Sector
Health CareCEO
Stephen Carter
Website
www.neuroscientific.comHeadquarters
Cottesloe, WA 6011, AU
NSB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-30%
Return on Capital
-22%
Return on Assets
-19%
Earnings Yield
-15.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.26M
Shares Outstanding
332.58M
Volume
98.86K
Short Interest
0.00%
Avg. Volume
376.16K
Financials (TTM)
Gross Profit
$92.78K
Operating Income
$1.92M
EBITDA
$1.92M
Operating Cash Flow
$941.33K
Capital Expenditure
$0.00
Free Cash Flow
$941.33K
Cash & ST Invst.
$7.27M
Total Debt
$0.00
NeuroScientific Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$622.76K
-1367.7%
Gross Margin
0.00%
N/A
Market Cap
$33.26M
N/A
Market Cap/Employee
$3.70M
N/A
Employees
9
N/A
Net Income
$1.70M
-38.2%
EBITDA
$1.51M
-27.3%
Quarterly Fundamentals
Net Cash
$6.36M
+90.5%
Accounts Receivable
$116.17K
+213.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-19.07%
N/A
Return on Invested Capital
-22.45%
N/A
Free Cash Flow
$480.55K
-130.3%
Operating Cash Flow
$480.55K
-130.3%